Evidence map›Paper›PMID 30962589›Full record

ReviewNature immunology2019

Innate immunity to intracellular LPS.

Vijay A K Rathinam, Yue Zhao, Feng Shao

Open access · greenAbstract readReview
In one paragraph

Review in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 343 papers.

0numbers the graph read from it
0cells of the map it votes in
343citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

343 citing papers in PubMed, 594 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ligand-Engineered CuSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  5. HypervirulentMicrobiology spectrum · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

283 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Vijay A K Rathinam *Department of Immunology, UConn Health School of Medicine, Farmington, CT, USA. rathinam@uchc.edu.
Yue Zhao *National Institute of Biological Sciences, Beijing, China.
Feng ShaoNational Institute of Biological Sciences, Beijing, China. shaofeng@nibs.ac.cn.ORCID http://orcid.org/0000-0002-9562-7791
National Institute of Biological Sciences, Beijing · CNUConn Health · US

Funding

Cytosolic Immune Surveillance During Bacterial InfectionsR01AI119015 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RATHINAM, VIJAY · 2016 to 2025
$4.0M
Characterization of noncanonical inflammasome-mediated release of alarminsR21AI135528 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RATHINAM, VIJAY · 2018 to 2019
$439k
NIAID NIH HHS R01 AI119015NIAID NIH HHS R21 AI135528NIH HHS R01AI119015NIH HHS R21AI 135528
6 · The paper itself

Abstract

Monitoring of the cytosolic compartment by the innate immune system for pathogen-encoded products or pathogen activities often enables the activation of a subset of caspases. In most cases, the cytosolic surveillance pathways are coupled to activation of caspase-1 via canonical inflammasome complexes. A related set of caspases, caspase-11 in rodents and caspase-4 and caspase-5 in humans, monitors the cytosol for bacterial lipopolysaccharide (LPS). Direct activation of caspase-11, caspase-4 and caspase-5 by intracellular LPS elicits the lytic cell death called 'pyroptosis', which occurs in multiple cell types. The pyroptosis is executed by the pore-forming protein GSDMD, which is activated by cleavage mediated by caspase-11, caspase-4 or caspase-5. In monocytes, formation of GSDMD pores can induce activation of the NLRP3 inflammasome for maturation of the cytokines IL-1β and IL-18. Caspase-11-mediated pyroptosis in response to cytosolic LPS is critical for antibacterial defense and septic shock. Here we review the emerging literature on the sensing of cytosolic LPS and its regulation and pathophysiological functions.

Indexed as

AnimalsCaspasesCytosolGasderminsHumansImmunity, InnateIntracellular Signaling Peptides and ProteinsLipopolysaccharidesModels, ImmunologicalNeoplasm ProteinsPhosphate-Binding ProteinsPyroptosisCaspasesGasderminsGSDMD protein, humanIntracellular Signaling Peptides and ProteinsLipopolysaccharidesNeoplasm ProteinsPhosphate-Binding Proteins

Identifiers

PMID30962589
PMCPMC7668400
OpenAlexW2936704425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.